Clown-Free Zone... sorry, no clowns allowed Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Clown-Free Zone... sorry, no clowns allowed

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Lucretius who wrote (244122)	6/5/2003 2:03:17 PM
From: MythMan	Read Replies (3) of 436258

You don't see this everyday -ng- >>RESEARCH ALERT-Morgan Stanley cuts Johnson & Johsnon target Thursday June 5, 12:00 pm ET NEW YORK, June 5 (Reuters) - Morgan Stanley on Thursday said it cut its price target for shares of Johnson & Johnson (NYSE:JNJ - News), a leading healthcare products company, to $49 from $59 for reasons including "concerns over its Procrit and Remicade franchises." "We think that JNJ should probably trade no better than the average pharmaceutical company over the next six months," analyst Glenn Reiein said in a research note. Shares of Johnson & Johnson closed at $54.06 on the New York Stock Exchange (News - Websites) on Wednesday.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next